Gyre Therapeutics GAAP EPS of $0.00, revenue of $26.8M
Source: SeekingAlpha
2025-08-11 16:29:45 ET
More on Gyre Therapeutics
- Gyre Therapeutics: Unique Business Model, Unique Challenges
- Gyre Therapeutics slumps 16%, prices $20M stock offering
- Gyre Therapeutics commences underwritten public offering
- Seeking Alpha’s Quant Rating on Gyre Therapeutics
- Historical earnings data for Gyre Therapeutics
Read the full article on Seeking Alpha
For further details see:
Gyre Therapeutics GAAP EPS of $0.00, revenue of $26.8M
Gyre Therapeutics Inc.
NASDAQ: GYRE
GYRE Trading
-4.69% G/L:
$7.615 Last:
87,188 Volume:
$7.98 Open:
GYRE Latest News
GYRE Stock Data
$767,775,261
71,190,203
0.16%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
